Alembic Pharmaceuticals Limited (NSE:APLLTD)
India · Delayed Price · Currency is INR 912.00
+10.65 (1.18%)
Oct 1, 2025, 3:29 PM IST
Alembic Pharmaceuticals Market Cap
Alembic Pharmaceuticals has a market cap or net worth of 177.75 billion as of October 2, 2025. Its market cap has decreased by -25.16% in one year.
Market Cap
177.75B
Enterprise Value
189.48B
Revenue
68.21B
Ranking
n/a
PE Ratio
29.46
Stock Price
912.00
Market Cap Chart
Since September 21, 2011, Alembic Pharmaceuticals's market cap has increased from 9.00B to 177.75B, an increase of 1,874.66%. That is a compound annual growth rate of 23.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2025 | 177.75B | -15.19% |
| Dec 31, 2024 | 209.59B | 40.41% |
| Dec 29, 2023 | 149.27B | 32.55% |
| Dec 30, 2022 | 112.61B | -28.56% |
| Dec 31, 2021 | 157.62B | -22.43% |
| Dec 31, 2020 | 203.20B | 88.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,925.79B |
| Divi's Laboratories | 1,515.83B |
| Cipla | 1,222.15B |
| Apollo Hospitals Enterprise | 1,069.90B |
| Mankind Pharma | 1,006.97B |
| Zydus Lifesciences | 997.33B |
| Fortis Healthcare | 747.14B |
| Alkem Laboratories | 652.77B |